Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about boron technology
Pipeline

Utilizing our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

 
Pipeline Graphic
 
 
New Releases

Thursday, July 23, 2015 | Anacor Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 6, 2015
Monday, July 13, 2015 | Anacor Pharmaceuticals Announces Positive Top-Line Results From Two Phase 3 Pivotal Studies of Crisaborole Topical Ointment, 2% in Patients With Mild-to-Moderate Atopic Dermatitis
Sunday, July 12, 2015 | Anacor Pharmaceuticals to Host Conference Call Tomorrow, July 13, 2015 at 7:30 A.M. ET to Discuss Top-Line Results From Crisaborole Phase 3 Pivotal Studies in Patients With Mild-to-Moderate Atopic Dermatitis
 
New Releases Graphic